Y-Intercept (HK)’s Caribou Biosciences CRBU Stock Holding History

Y-Intercept (HK)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-137,211	Closed	-$173K	–	1639
2025 Q2	$173K	Buy	+137,211	New	+$135K	﹤0.01%	1484
2024 Q3	–	Sell	-21,989	Closed	-$36.1K	–	1388
2024 Q2	$36.1K	Buy	21,989 +11,604	+112%	+$37.1K	﹤0.01%	1314
2024 Q1	$53.4K	Buy	+10,385	New	+$64K	﹤0.01%	1302
2023 Q3	–	Sell	-44,155	Closed	-$188K	–	1134
2023 Q2	$188K	Buy	+44,155	New	+$198K	0.02%	951

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Y-Intercept (HK)'s CRBU Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Caribou Biosciences (CRBU) in Q3 2025, closing a stake of 137,211 shares — an estimated $173K sold.

Y-Intercept (HK) first reported a position in CRBU in Q2 2023 and held it in 4 quarters. The position peaked at $188K in Q2 2023. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

Y-Intercept (HK) reported no remaining Caribou Biosciences position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 137,211 Caribou Biosciences shares in Q3 2025, an estimated $173K.
Y-Intercept (HK) first reported a position in Caribou Biosciences in Q2 2023 and held it in 4 quarters.
Y-Intercept (HK)'s Caribou Biosciences position peaked at $188K in Q2 2023.
117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.